CytoMed Therapeutics Ltd - GDTC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$11K
QoQ value delta ($000)
-$5K (-31.25%)
Implied price effect (QoQ)
-5.48%
Shares
Total shares
11,884
QoQ shares delta
-4,455 (-27.27%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GDTC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Axiom Investment Management LLC 7 7,032 0.0%
UBS Group AG 4 4,831 0.0%
OSAIC HOLDINGS, INC. 0 21 0.0%